JMSB

John Marshall Bancorp is a ~$2.33B-asset Virginia commercial bank showing a genuine, filing-corroborated earnings recovery. FY2025 net income rose 24% to $21.2M and diluted EPS grew 24.2% to $1.49, driven almost entirely by the balance sheet re-pricing: net interest income jumped from $51.0M to $60.6M as interest expense actually fell ($59.1M → $52.7M) even while interest income rose, lifting net interest margin from 2.28% to 2.68%. Operating leverage improved in lockstep — the efficiency ratio fell from 59.7% to 53.6% — so this is higher-quality earnings growth, not a one-off. Credit and capital are pristine: nonperforming assets are just 0.05% of total assets (down from 0.45%), allowance coverage of nonperformers leapt to 18.3x from 1.9x, net charge-offs were negligible at 0.02%, and bank-level CET1 is 15.2% with a 12.5% leverage ratio — ample cushion against the credit risk the 10-K flags around its small/medium business and CRE-heavy book.

The problem is that quality is priced fairly, not cheaply. At $22.17 the stock trades at 14.9x FY2025 EPS and about 1.19x the $18.69 book value per share — a full multiple for a bank whose return on equity is only ~8.0% (ROAE 8.26%). An 8% ROE roughly equals or trails a bank's cost of equity, which is precisely why the market pays only ~1.2x book; there is no valuation gift here. The earnings history also demands humility: net income swung from $31.8M (2021 tail/2022) to just $5.16M in 2023 before recovering, showing how sharply this thin-margin, rate-sensitive franchise can compress when funding costs spike. The 2.68% NIM, while improved, is still low, and the recovery leans on a benign rate/funding path continuing.